USTR Extends Certain Exclusions from Section 301 Tariffs for COVID Treatment Products until May 2022USTR Extends Certain Exclusions from Section 301 Tariffs for COVID Treatment Products until May 2022
- November 10, 2021
The Office of the U.S. Trade Representative (USTR) announced that it will extend 81 of 99 Section 301 tariff exclusions on products used to treat COVID-19 for an additional 6 months; these exclusions were originally set to expire on November 14, 2021.
The extended exclusions will apply to products meeting the specified criteria until May 31, 2022.
The USTR also announced that the remaining 18 exclusions—also set to end on November 14— will not be renewed and will instead expire on November 30, 2021.
Click here to access the official USTR notice, which includes the list of 81 extended products in the Annex.
All importers who have an eligible product are able to claim an exemption under the exclusions, regardless of whether the importer filed an exclusion request. It is possible the USTR will continue to issue decisions on pending exclusion requests on a periodic basis.
As always, we encourage you to contact our compliance experts with any questions or for assistance with the exclusion process.
Shapiro will also continue to monitor and provide status updates on our Section 301 Tariff News page as they become available.